SRI, Amylyx Pharmaceuticals partner to identify ALS drug candidates
SRI and Amylyx have joined forces to develop new drug candidates to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Page 2 - Child Level Menu Hover News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Child Level Menu Hover. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Child Level Menu Hover Today - Breaking & Trending Today
Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment
Mogrify has collaborated with Astellas Pharma to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss.
ViGeneron signs collaboration agreement with Regeneron Pharmaceuticals
ViGeneron, a Germany-based gene therapy company, has entered a target-specific strategic collaboration and option agreement with Regeneron Pharmaceuticals.
Bristol Myers Squibb gets FDA approval for metastatic melanoma therapy
Bristol Myers Squibb has obtained approval from the US FDA for Opdualag to treat unresectable or metastatic melanoma patients.
Sanofi, Blackstone partner to advance multiple myeloma treatment
Sanofi has announced a collaboration with investment management firm Blackstone to advance an innovative treatment for multiple myeloma.